AKEBIA THERAPEUTICS, INC. (AKBA) Free cash flow 2016–2025
AKEBIA THERAPEUTICS, INC. (AKBA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$67.7MFY2025 · since FY2016: $55.2M → $67.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $67.7M | +266.4% |
| FY2024 | -$40.7M | -74.0% |
| FY2023 | -$23.4M | +68.1% |
| FY2022 | -$73.3M | +71.0% |
| FY2021 | -$253.0M | -128.6% |
| FY2020 | -$110.7M | +58.1% |
| FY2019 | -$264.1M | -166.5% |
| FY2018 | -$99.1M | -71.5% |
| FY2017 | -$57.8M | -204.6% |
| FY2016 | $55.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice